From our base in the UAE we run regulatory and go-to-market programmes across six regions. Where we have delivered projects ourselves, we say so; elsewhere we work through vetted in-market regulatory and commercial partners, coordinated by our team.
Europe & UK
- Delivered: EU MDR (Germany), ISO 13485 (UK)
- Also: UKCA, notified-body selection, national reimbursement listings
Middle East & GCC
- Delivered: SFDA MDMA (Saudi Arabia), MoHAP registration (UAE)
- Channels: NUPCO and government tenders, private hospital groups, insurers, distributor networks
Africa
- Regulatory landscape and country prioritisation, volume estimates, distributor and NGO channels, government and donor-funded programmes
Central & South Asia
- Delivered: CDSCO registration (India)
- Channels: private clinics, government schemes, clinical networks; market insight through Bharat CPO
Southeast Asia & APAC
- Also: TGA (Australia) and key Southeast Asian regulators; distributor search and onboarding
The Americas
Hugh Sheridan has built and sold into the US market from both sides: as a commercial leader of a US-facing digital health start-up and as Group CEO of a global foot health business.
- Andiamo, Chief Commercial Officer: led go-to-market for a digital platform for children with cerebral palsy, set up five strategic partnerships through clinical resellers, generated $4 million in revenue and a $25 million pipeline, and reached $44,000 in monthly recurring revenue within six months serving families across the USA
- Entrepreneurs Roundtable Accelerator, New York: graduate of New York City’s leading technology accelerator
- Algeos, Group CEO: led a team of 100 foot health specialists across five continents, achieved ISO 13485 certification within five months, and drove record revenue of $20 million with the highest operating profit in the company’s history
- Regulatory: ISO 13485 in Canada, plus FDA and Health Canada and ANVISA and Latin American registrations
